USP Pharmaceutical Analytical Impurities

(4,9-Diisobutyl-1,6-diazecane-2,7-dione)

(7,7'-((oxybis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one))

(7,7'-(butane-1,4-diylbis(oxy))bis(3,4-dihydroquinolin-2(1H)-one))

(7-(4-chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one)

(7-(4-(4-(2-bromophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one, hydrochloride)

(7-(4-(4-(3-chlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)

(7,7'-((((ethane-1,1-diylbis(2,3-dichloro-4,1-phenylene))bis(piperazine-4,1-diyl))bis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one)

(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid)

(7-(4-bromobutoxy)quinolin-2(1H)-one)

(5-(4-bromobutoxy)-3,4-dihydroquinolin-2(1H)-one)

(7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)-3,4-dihydroquinolin-2(1H)-one)

(3,4-dihydro-8-hydroxy-2(1H)-Quinolinone)

(4-(2,3-dichlorophenyl)-1-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazine 4-oxide)

(5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)

(8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium, bromide)

(7-hydroxy-3,4-dihydroquinolin-2(1H)-one)

(7-hydroxyquinolin-2(1H)-one)

(7-(4-(4-(2-chlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)

(N1-(2-chloroethyl)-N2-(2,3-dichlorophenyl)ethane-1,2-diamine, hydrochloride)

(1,4-bis(4-(2,3-dichlorophenyl)piperazin-1-yl)butane, hydrochloride)

((E)-1-{3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl}-4-(2,4,5-trifluorophenyl)but-2-en-1-one)

((E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one)

((R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione)

((S)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate)